Skip to main content

ZURICH HEART HOUSE

The Zurich Heart House creates and communicates new knowledge in the field of cardiovascular diseases. Through its affiliation with the University of Zurich, the editorial mandate of the "European Heart Journal" and as the seat of the "Foundation for Cardiovascular Research", the Zurich Heart House is one of the most important cardiology research and education centres in Europe.

The Zurich Heart House is a place of creative knowledge exchange between researchers, scientists, clinicians, practicing physicians, lecturers and staff. As a think tank, it is intended to strengthen Zurich as a location and serve as a service centre for doctors and patients with cardiovascular diseases.


Annual Report 2023*

*in German

 


 

Applications for the PCHF London 2025 - 2026 | 4th Edition are now OPEN!

PCHFL4thEdition

 

ZHH News

CMM

Postgraduate Course in Cardiometabolic Medicine 2024 | Replay videos are NOW available on demand!

The video recordings of the  2024 Postgraduate Course in Cardiometabolic Medicine are now available on demand HERE!

Florian

Research Prize of the Swiss Society of Cardiology: Congratulations to Dr. Florian Wenzl!

The 2024 Research Prize of the Swiss Society of Cardiology goes to Dr. Florian Wenzl for his outstanding original research on ‘Personalised Treatment of Acute Coronary Syndromes’ and in recognition of his exemplary dedication and evolving contributions to cardiology.

Florian

Rising stars in cardiology: Florian A. Wenzl

Florian A. Wenzl, MD, of the Center for Molecular Cardiology at the University of Zurich, Switzerland, is making a name for himself in the field of risk prediction in cardiovascular disease. A project that focused on predicting adverse outcomes in patients with acute coronary syndromes (ACSs) earned him a European Society of Cardiology (ESC) Young Investigator Award (YIA) in Clinical Science at the 2023 Congress Read more here (European Heart Journal (2024) 00, 1–2)!

Cardiology News

Cardiac Sarcoidosis

Management of cardiac sarcoidosis

A clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial & Pericardial Diseases, and the European Heart Rhythm Association of the ESC

Read full article (European Heart Journal (2024) 00, 1–30)

 

SNFHerzmedizin

Am Puls der Herzmedizin

Herz-Kreislauf-Erkrankungen sind die häufigste Todesursache in der Schweiz, entsprechend intensiv wird das Pumporgan erforscht. Sechs innovative Projekte.

1 — KI für Symptome bei Frauen Europaweite Analyse, Universität Zürich

Erfahren Sie mehr HIER (Horizonte, Dezember 2023)

Cardiac Sarcoidosis

Cardiac Sarcoidosis – An Underrecognized Myocardial Disease

Sarcoidosis is a multisystemic, chronic inflammatory disorder involving lymph nodes and lungs characterized by a non-caseating, epithelioid cell granulomatous inflammation of affected organs. Cardiac involvement has been reported in 5-30% depending on the diagnostic criteria.

Read full article (Cardiovasc Med | 2024;27(1):1–3)